2018 Korean clinical imaging guideline for hemoptysis

Mi Jin Kang, Jin Hwan Kim, Yoon Kyung Kim, Hyun Joo Lee, Kyung Min Shin, Jung Im Kim, Hyun Ju Lee, Kyung Hyun Do, Hwan Seok Yong, Sol Ji Choi, Miyoung Choi, Jung Im Jung

    Research output: Contribution to journalReview articlepeer-review

    11 Citations (Scopus)


    In 2014, the American College of Radiology (ACR) announced the guideline for the appropriate diagnostic approach and treatment of patients according to the severity of hemoptysis and risk for lung cancer. However, the application of the ACR guideline in Korea may not be appropriate, because many patients in Korea have active tuberculosis or pulmonary fibrosis due to previous tuberculosis. The Korean Society of Radiology and Korean Society of Thoracic Radiology have proposed a new guideline suitable for Korean practice. This new guideline was prepared through the consensus of a development committee, working party, and an advisory committee. The guideline proposal process was based on an evidence-based clinical imaging guideline proposed by the development committee. Clinical imaging guideline for adult patients with hemoptysis is as follows: Chest radiography is an initial imaging modality to evaluate hemoptysis. Contrast-enhanced chest CT is recommended in patients with two risk factors for lung cancer (> 40 years old and > 30 pack-year smoking history), moderate hemoptysis (> 30 mL/24 hours) or recurrent hemoptysis. Contrast-enhanced chest CT is also recommended in patients with massive hemoptysis (> 400 mL/24 hours) without cardiopulmonary compromise.

    Original languageEnglish
    Pages (from-to)866-871
    Number of pages6
    JournalKorean journal of radiology
    Issue number5
    Publication statusPublished - 2018 Sept 1

    Bibliographical note

    Funding Information:
    This study was supported by the National Evidence-based Collaborating Agency (NECA-C-15-003) and the Korean Society of Radiology (NECA-S-15-002).

    Funding Information:
    Received February 22, 2018; accepted after revision April 3, 2018. This study was supported by the National Evidence-based Collaborating Agency (NECA-C-15-003) and the Korean Society of Radiology (NECA-S-15-002). This Guideline has been published jointly by invitation and consent in both the Journal of the Korean Society of Radiology (in Korean) and the Korean Journal of Radiology (in English). Corresponding author: Jung Im Jung, MD, PhD, Department of Radiology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul 06591, Korea. • Tel: (822) 2258-1435 • Fax: (822) 599-6771 • E-mail: [email protected] This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https:// creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

    Publisher Copyright:
    © 2018 The Korean Society of Radiology.


    • Computed tomography
    • Evidence
    • Guideline
    • Hemoptysis
    • Lung
    • Radiography
    • Republic of korea
    • Thorax
    • X-ray

    ASJC Scopus subject areas

    • Radiology Nuclear Medicine and imaging


    Dive into the research topics of '2018 Korean clinical imaging guideline for hemoptysis'. Together they form a unique fingerprint.

    Cite this